Heart failure and cardiomyopathy are significant contributors to pregnancy-related deaths,
as maternal morbidity and mortality have been increasing over time. In this setting, the role …

Despite the evidence demonstrating the clinical utility of cardiac specific biomarkers in
improving cardiovascular risk evaluation in several clinical conditions, even the most recent …

Background Physiologic changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP)
across trimesters of pregnancy have not been well studied. Objectives The authors aimed to …

Hypertensive disorders of pregnancy (HDP) are among the major causes of high maternal
and fetal/neonatal morbidity and mortality rates. Patients with HDP have significantly …

Cardiovascular disease is the primary cause of pregnancy-related mortality and morbidity in
the United States, and maternal mortality has increased over the last decade. Pregnancy …

For many years, women diagnosed with pulmonary arterial hypertension (PAH) received
advice against pregnancy due to a significant mortality risk [1, 2]. With therapeutic …

Preeclampsia remains the leading cause of maternal morbidity and mortality and is
associated with abnormal body fluid homeostasis and cardiovascular dysfunction. Two …

Valvular heart disease is a common cause of peripartum cardiovascular morbidity and
mortality. The hemodynamic changes of pregnancy and their impact on preexisting valvular …

Many studies have demonstrated the crucial pathophysiological and clinical relevance to
evaluate cardiac specific biomarkers (natriuretic peptides and cardiac troponins) for the …

Objective: The objective of this study was to compare the levels of Serum Activin A and
Inhibin A in Pregnancy induced hypertension, Preeclampsia & Normal Pregnancy Material …